Blog
RSS FeedPosted by Michael Wonder on 16 Dec 2018
Transparency Commission publishes its opinion for Kymriah
14 December 2018 - Opinion published following an examination of written submissions on 12 December 2018. ...
Posted by Michael Wonder on 09 Dec 2018
Transparency Commission publishes its opinion for Yescarta
7 December 2018 - Opinion published following an examination of written submissions on 5 December 2018. ...
Posted by Michael Wonder on 21 Jun 2017
Transparency Commission publishes opinion for Keytruda
20 June 2017 - The opinion relates to the use of pembrolizumab for the first-line use in patients with non-small-cell ...
Posted by Michael Wonder on 02 Jun 2017
Transparency Commission revises ASMR for Imbruvica
1 June 2017 - The Transparency Commission has published its revised opinion on the ASMR for ibrutinib for patients with ...
Posted by Michael Wonder on 25 May 2017
Transparency Commission publishes its review of Keytruda's SMR & ASMR
22 May 2017 - The Transparency Commission has reviewed its SMR & ASMR ratings of pembrolizumab for malignant melanoma. ...
Posted by Michael Wonder on 15 May 2017
TC publishes opinion on Pfizer's Ibrance
11 May 2017 - The Commission considers that the medical service rendered by palbociclib when used in combination with letrozole ...
Posted by Michael Wonder on 12 Apr 2017
HAS publishes Transparency Commission opinion for Keytruda
12 April 2017 - The opinion relates the use of pembrolizumab by patients with non-small-cell lung cancer. ...